Skip to Content
Merck
  • Thermographic monitoring of wound healing and oral health-related quality of life in patients treated with laser (aPDT) after impacted mandibular third molar removal.

Thermographic monitoring of wound healing and oral health-related quality of life in patients treated with laser (aPDT) after impacted mandibular third molar removal.

International journal of oral and maxillofacial surgery (2014-10-04)
G Batinjan, Z Zore, A Čelebić, M Papić, D Gabrić Pandurić, I Filipović Zore
ABSTRACT

The objective of this study was to assess the impact of low-level laser therapy on wound swelling, wound temperature changes, and oral health-related quality of life (OHRQoL) after surgical removal of impacted lower third molars. Forty patients with impacted lower third molars requiring surgical removal participated in this study; all were Pell-Gregory class IIB or IIC. The patients were divided randomly into two groups for post-extraction therapy. One group received antimicrobial photodynamic therapy (aPDT) and the other received no additional therapy (placebo group). Temperature measurements were done using an infrared thermographic camera on days 3 and 7 postoperative. OHRQoL was assessed in both groups on day 7 using the Oral Health Impact Profile questionnaire translated into Croatian (OHIP-14-CRO). Prior to surgical treatment, there was no difference in patient characteristics between the two groups. A significantly lower temperature and less wound swelling were recorded on day 3 postoperative in the aPDT group compared to the control group (P<0.001). Participants in the aPDT group also had significantly lower OHIP-14-CRO summary scores (P<0.01). The present study showed beneficial effects of the aPDT modality of low-level laser therapy: postoperative wound swelling was reduced and wound temperature decreased, and OHRQoL was better through the 7-day postoperative period in comparison to the placebo group.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
(±)-Epinephrine hydrochloride
Articaine hydrochloride, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
Articaine hydrochloride, ≥98% (HPLC)